Responder analysis using clinically meaningful thresholds: Post hoc analyses from randomized dupilumab clinical trials in patients with prurigo nodularis.

Shawn G KwatraGil YosipovitchPamela GuglielminiIsabelle GuilleminJérôme MsihidAshish BansalMelanie MakhijaSimmi WigginsJoseph ZahnRyan B ThomasDonia Bahloul

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2024)

Significantly greater proportion of dupilumab-treated patients with PN, versus placebo, demonstrated clinically meaningful improvements in PRO measures of symptoms and QoL.

Keyphrases

atopic dermatitis
clinical trial
double blind
phase iii
placebo controlled
phase ii
open label
sleep quality